🔴 Moleculin Biotech is trading 9.06% down today after announcing a 1-for-20 reverse split

Moleculin Biotech is trading 9.06% down at $0.26 after its October 16 announcement of a 1-for-20 reverse stock split.

• The split takes effect October 20, reducing outstanding shares from approximately 20.9 million to 1.05 million.
• Shares closed at $0.28 October 16, down 24.24%, after earlier-week consecutive losses; reports linked the announcement to an earlier premarket selloff.
• No separate October 19 announcement or volume figure was identified; mixed market context does not clearly explain the move.